Tapewire

NYSE · USD

AORT

ARTIVION, INC.

Export transactions ↓
Tapewire entity
4767
SEC CIK
0000784199
Parsed reports
700

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025024
Dec 202506
Jan 202600
Feb 2026012
Mar 2026013
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202604
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 24, 2025 Filed Feb 26, 2025 18:54 UTC
Davis John EChief Commercial Officer
SaleCommon Stock 2,846 $27.31 $77,712.88
Disclosure

SEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,242

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:50 UTC
Berry Lance AExecutive VP, CFO
SaleCommon Stock 3,259 $27.31 $88,990.25
Disclosure

SEC source: 0000784199-25-000016 · wk-form4_1740595839.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · Executive VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,805

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:46 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 1,246 $27.31 $34,023.28
Disclosure

SEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 4

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,845

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:46 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 672 $27.31 $18,349.63
Disclosure

SEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 3

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,091

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:46 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 470 $27.31 $12,833.82
Disclosure

SEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,763

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:46 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 2,299 $27.31 $62,776.49
Disclosure

SEC source: 0000784199-25-000014 · wk-form4_1740595575.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,233

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
December 31, 2024 Filed Jan 30, 2025 15:13 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 381 $21.63 $8,241.03
Disclosure

SEC source: 0000784199-25-000004 · wk-form5_1738249991.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,532

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
December 31, 2024 Filed Jan 30, 2025 15:09 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 295 $21.63 $6,380.85
Disclosure

SEC source: 0000784199-25-000002 · wk-form5_1738249772.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,134

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 20:31 UTC
Horton AmyVP, Chief Accounting Officer
GiftCommon Stock 1,100 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000262 · wk-form4_1734121861.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,464

F1 · shares: 1,100 shares were gifted by the reporting person to a charity.

Read SEC document
December 11, 2024 Filed Dec 12, 2024 21:11 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 4,035 $30.00 $121,050.00
Disclosure

SEC source: 0000784199-24-000260 · wk-form4_1734037903.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,862

F1 · price: Reflects the price the shares were sold.

Read SEC document
December 11, 2024 Filed Dec 12, 2024 21:11 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 4,035 $30.25 $122,058.75
Disclosure

SEC source: 0000784199-24-000260 · wk-form4_1734037903.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,897

F1 · price: Reflects the price the shares were sold.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 20:34 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 4,329 $29.66 $128,398.14
Disclosure

SEC source: 0000784199-24-000256 · wk-form4_1733776456.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,660

F1 · shares: These shares were sold upon the vesting of Restricted Stock Units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 20:45 UTC Amendment
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 4,425 $29.05 $128,551.56
Disclosure

SEC source: 0000784199-24-000258 · wk-form4a_1733863511.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,564

F1 · shares: These shares were sold upon the vesting of Restricted Stock Units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on December 6, 2024. The original Form 4 reported that 4,329 shares were sold, when in fact, 4,425 shares were sold.

F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transaction on December 6, 2024, the number of shares reported as beneficially owned in this amendment reflects a decrease in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
December 04, 2024 Filed Dec 4, 2024 21:11 UTC
GREEN ANDREW MVP Regulatory
SaleCommon Stock 7,618 $30.00 $228,540.00
Disclosure

SEC source: 0000784199-24-000245 · wk-form4_1733346705.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,503

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 13, 2024.

F2 · price: Reflects the price the shares were sold.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 22:44 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 12,430 $0.00 Strike: $21.55 $0.00
Disclosure

SEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · derivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,430 shares

Expires 2025-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 22:44 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 12,430 $26.18 $325,414.91
Disclosure

SEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,989

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

F2 · price: Reflects weighted average price. Range of prices were between $26.00 to $26.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 22:44 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionCommon Stock 12,430 $21.55 $267,866.50
Disclosure

SEC source: 0000784199-24-000231 · wk-form4_1727909080.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 11, 2024.

Read SEC document
August 26, 2024 Filed Aug 27, 2024 20:47 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 3,167 $26.55 $84,095.88
Disclosure

SEC source: 0000784199-24-000224 · wk-form4_1724791614.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,932

F1 · price: Reflects weighted average price for Restricted Stock Awards. Range of prices were between $26.55 to $26.61. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 16, 2024 Filed Aug 19, 2024 20:58 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 2,562 $25.31 $64,848.06
Disclosure

SEC source: 0000784199-24-000222 · wk-form4_1724101102.xml · nonDerivative · entry 2

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,116

F2 · price: Reflects weighted average price for Restricted Stock Units. Range of prices were between $25.30 to $25.34. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 16, 2024 Filed Aug 19, 2024 20:58 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 6,858 $25.31 $173,586.27
Disclosure

SEC source: 0000784199-24-000222 · wk-form4_1724101102.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,678

F1 · price: Reflects weighted average price for Performance Stock Units. Range of prices were between $25.30 to $25.34. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 15:38 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 2,383 $25.76 $61,392.99
Disclosure

SEC source: 0000784199-24-000220 · wk-form4_1723822725.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,099

F1 · price: Reflects the price the shares were sold.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 14:37 UTC SaleCommon Stock 9,709 $24.99 $242,627.91
Disclosure

SEC source: 0000784199-24-000218 · wk-form4_1723732622.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,159

F1 · price: Reflects the price the shares were sold.

Read SEC document
June 30, 2024 Filed Jan 30, 2025 15:13 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 855 $15.20 $12,996.00
Disclosure

SEC source: 0000784199-25-000004 · wk-form5_1738249991.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,151

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
June 30, 2024 Filed Jan 30, 2025 15:16 UTC
Davis John EChief Commercial Officer
GrantCommon Stock 1,398 $15.20 $21,249.60
Disclosure

SEC source: 0000784199-25-000006 · wk-form5_1738250165.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,088

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
June 30, 2024 Filed Jan 30, 2025 15:09 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 977 $15.20 $14,850.40
Disclosure

SEC source: 0000784199-25-000002 · wk-form5_1738249772.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,839

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:44 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000203 · wk-form4_1717418645.xml · nonDerivative · entry 1

ACKERMAN THOMAS F · CIK 0001141720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,571

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:41 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000201 · wk-form4_1717418454.xml · nonDerivative · entry 1

BEVEVINO DANIEL J · CIK 0001186458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,736

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:38 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000199 · wk-form4_1717418330.xml · nonDerivative · entry 1

Salveson Jon W · CIK 0001372026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,515

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:36 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000197 · wk-form4_1717418172.xml · nonDerivative · entry 1

Bullock James · CIK 0001172340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,322

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:33 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000195 · wk-form4_1717417977.xml · nonDerivative · entry 1

Burbank Jeffrey H · CIK 0001341411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,471

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:29 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000193 · wk-form4_1717417776.xml · nonDerivative · entry 1

Borgstrom Marna P · CIK 0001744267 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,763

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:24 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000191 · wk-form4_1717417489.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,868

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 12:22 UTC GrantCommon Stock 6,289 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000189 · wk-form4_1717417360.xml · nonDerivative · entry 1

Hoff Elizabeth A · CIK 0001949762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,064

F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
May 10, 2024 Filed May 13, 2024 22:05 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 1,250 $23.42 $29,275.13
Disclosure

SEC source: 0000784199-24-000176 · wk-form4_1715637944.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,482

F1 · price: Reflects the price the shares were sold.

Read SEC document
May 09, 2024 Filed May 10, 2024 21:12 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 979 $23.79 $23,285.52
Disclosure

SEC source: 0000784199-24-000174 · wk-form4_1715375556.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,732

F1 · price: Reflects the price the shares were sold.

Read SEC document
March 20, 2024 Filed Mar 21, 2024 21:14 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 2,183 $20.39 $44,511.37
Disclosure

SEC source: 0000784199-24-000164 · wk-form4_1711055634.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,296

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 22:09 UTC
GREEN ANDREW MVP Regulatory
SaleCommon Stock 1,462 $20.00 $29,240.00
Disclosure

SEC source: 0000784199-24-000162 · wk-form4_1710799753.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,121

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2023.

F2 · price: Reflects the price the shares were sold.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:20 UTC
GREEN ANDREW MVP Regulatory
SaleCommon Stock 3,994 $20.00 $79,880.00
Disclosure

SEC source: 0000784199-24-000160 · wk-form4_1710537608.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,583

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2023.

F2 · price: Reflects the price the shares were sold.

Read SEC document
March 12, 2024 Filed Mar 15, 2024 01:06 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 5,000 $19.94 $99,719.50
Disclosure

SEC source: 0000784199-24-000158 · wk-form4_1710464762.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,536

F1 · price: Reflects weighted average price. Range of prices were between $19.90 to $20.015. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:20 UTC
Mackin James PPresident & CEO
SaleCommon Stock 13,996 $18.72 $262,037.31
Disclosure

SEC source: 0000784199-24-000108 · wk-form4_1709853614.xml · nonDerivative · entry 2

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 705,562

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:16 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 2,380 $18.72 $44,558.84
Disclosure

SEC source: 0000784199-24-000106 · wk-form4_1709853394.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,669

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:14 UTC
Davis John EChief Commercial Officer
SaleCommon Stock 2,022 $18.72 $37,856.29
Disclosure

SEC source: 0000784199-24-000104 · wk-form4_1709853255.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,637

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:12 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 1,157 $18.72 $21,661.35
Disclosure

SEC source: 0000784199-24-000102 · wk-form4_1709853116.xml · nonDerivative · entry 2

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,503

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:10 UTC SaleCommon Stock 1,157 $18.72 $21,661.82
Disclosure

SEC source: 0000784199-24-000100 · wk-form4_1709852994.xml · nonDerivative · entry 2

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,536

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:07 UTC
GREEN ANDREW MVP Regulatory
SaleCommon Stock 1,160 $18.72 $21,717.64
Disclosure

SEC source: 0000784199-24-000098 · wk-form4_1709852827.xml · nonDerivative · entry 2

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,541

F2 · shares: 2. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:05 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 1,506 $18.72 $28,195.48
Disclosure

SEC source: 0000784199-24-000096 · wk-form4_1709852706.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,438

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:01 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 1,152 $18.72 $21,568.09
Disclosure

SEC source: 0000784199-24-000094 · wk-form4_1709852505.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,957

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
March 05, 2024 Filed Mar 15, 2024 00:09 UTC Amendment
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 1,152 $18.72 $21,568.09
Disclosure

SEC source: 0000784199-24-000130 · wk-form4a_1710461384.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,989

F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
March 05, 2024 Filed Mar 15, 2024 00:00 UTC Amendment SaleCommon Stock 1,157 $18.72 $21,661.82
Disclosure

SEC source: 0000784199-24-000122 · wk-form4a_1710460808.xml · nonDerivative · entry 2

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,569

F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
March 05, 2024 Filed Mar 14, 2024 23:55 UTC Amendment
Holloway Jean FSVP, General Counsel
SaleCommon Stock 2,380 $18.72 $44,558.84
Disclosure

SEC source: 0000784199-24-000118 · wk-form4a_1710460531.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,711

F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary transaction.

F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.